CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.02852 | 23.7666666667 | 0.12 | 0.1533 | 0.117 | 2764934 | 0.13778161 | CS |
4 | 0.00852 | 6.08571428571 | 0.14 | 0.1533 | 0.1051 | 2903261 | 0.12199641 | CS |
12 | -0.00148 | -0.986666666667 | 0.15 | 0.1533 | 0.1031 | 2673701 | 0.12428881 | CS |
26 | 0.00352 | 2.4275862069 | 0.145 | 0.209 | 0.1031 | 2455524 | 0.13415161 | CS |
52 | -0.05668 | -27.6218323587 | 0.2052 | 0.315 | 0.1031 | 2596614 | 0.15586641 | CS |
156 | -0.41148 | -73.4785714286 | 0.56 | 1.3 | 0.1031 | 2171632 | 0.29432116 | CS |
260 | -0.89148 | -85.7192307692 | 1.04 | 10.01 | 0.1031 | 3103443 | 2.00754294 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約